Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Cogent Biosciences, Inc. | cogt-ex322_8.htm |
| EX-32.1 - EX-32.1 - Cogent Biosciences, Inc. | cogt-ex321_9.htm |
| EX-31.2 - EX-31.2 - Cogent Biosciences, Inc. | cogt-ex312_11.htm |
| EX-31.1 - EX-31.1 - Cogent Biosciences, Inc. | cogt-ex311_10.htm |
| EX-21.1 - EX-21.1 - Cogent Biosciences, Inc. | cogt-ex211_111.htm |
| EX-10.24 - EX-10.24 - Cogent Biosciences, Inc. | cogt-ex1024_108.htm |
| EX-10.6 - EX-10.6 - Cogent Biosciences, Inc. | cogt-ex106_429.htm |
| EX-10.5 - EX-10.5 - Cogent Biosciences, Inc. | cogt-ex105_109.htm |
| EX-10.4 - EX-10.4 - Cogent Biosciences, Inc. | cogt-ex104_112.htm |
| EX-4.1 - EX-4.1 - Cogent Biosciences, Inc. | cogt-ex41_209.htm |
| 10-K - 10-K - Cogent Biosciences, Inc. | cogt-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-249884, 333-224137 and 333-230559) and Form S-3 (Nos. 333-252873 and 333-248971) of Cogent Biosciences, Inc. of our report dated March 16, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 16, 2021